Condition

Neuroendocrine Carcinoma clinical trials and research

• 14Clinical trials
• 6Countries

Newest Neuroendocrine Carcinoma clinical trials

All recruiting trials (14)

• Autologous B7-H3 CAR T Cells in Advanced Small Cell Lung Cancer and Extrapulmonary Neuroendocrine Cancer

  This study tests a patient’s own B7-H3 CAR T cells to see if they can help people 18 and older whose small cell lung cancer or EPNEC has come back or hasn’t responded to prior treatment.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07509034

• ZG006 plus ZG005 for advanced small cell lung cancer and neuroendocrine carcinoma

  This trial tests whether the combination of ZG006 and ZG005 helps adults with advanced small cell lung cancer or neuroendocrine carcinoma.

  Recruiting Phase 1/2 Suzhou Zelgen Biopharmaceuticals Co.,Ltd · Guanzhou, Guangdong · NCT07038096

• Tarlatamab versus standard chemotherapy for pre-treated advanced pulmonary (large-cell) or gastroenteropancreatic poorly differentiated neuroendocrine carcinomas

  This trial tests whether tarlatamab helps adults with DLL3-positive, pre-treated advanced pulmonary (large-cell) or gastroenteropancreatic poorly differentiated neuroendocrine carcinomas compared with standard chemotherapy.

  Recruiting at 40 sites Phase 3 Intergroupe Francophone de Cancerologie Thoracique · Angers and 39 other locations · NCT06937905

• Testing a new treatment for advanced neuroendocrine tumors

  This study is testing a new treatment combining a virus with two cancer drugs to see if it helps people with advanced neuroendocrine tumors feel better and tolerate the treatment well.

  Recruiting Phase 1 University of Miami · Miami, Florida · NCT06889493

• Testing ZG006 for advanced small cell lung cancer and neuroendocrine carcinoma

  This study is testing a new drug called ZG006 to see if it is safe and effective for people with advanced small cell lung cancer or neuroendocrine carcinoma.

  Recruiting Phase 1/2 Suzhou Zelgen Biopharmaceuticals Co.,Ltd · Beijing, Beijing Municipality · NCT06440057

• Understanding how non-small cell lung cancer transforms into neuroendocrine carcinoma

  This study is trying to see how non-small cell lung cancer changes into a different type called neuroendocrine carcinoma in patients with certain gene mutations who have stopped responding to their current treatments.

  Recruiting Fudan University · Shanghai, Shanghai Municipality · NCT06369181

• Dostarlimab treatment for advanced or metastatic cancers with specific genetic markers

  This study is testing if the immunotherapy dostarlimab can help people with certain advanced cancers that have specific genetic markers feel better compared to standard chemotherapy.

  Recruiting Phase 2 Unicancer · Angers and 21 other locations · NCT06333314

• Using a new type of PET scanner for imaging prostate cancer and related conditions

  This study is testing a new type of PET scanner to see if it can better detect early signs of prostate cancer and related conditions in patients.

  Recruiting Jagiellonian University · Krakow · NCT06242119

• Treatment of small cell lung cancer and neuroendocrine carcinoma with ZG006

  This study is testing a new drug called ZG006 to see if it can help adults with small cell lung cancer or neuroendocrine carcinoma who have run out of other treatment options.

  Recruiting Phase 1/2 Suzhou Zelgen Biopharmaceuticals Co.,Ltd · Zhengzhou, Henan · NCT05978284

• Surufatinib and Serplulimab with Platinum/Etoposide for Neuroendocrine Carcinoma

  This study tests a combination of targeted therapy, immunotherapy, and chemotherapy in adults with newly treated neuroendocrine carcinoma to see if the regimen is safe and helps shrink tumors.

  Recruiting Phase 1/2 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Hubei · NCT05747729

• Exploring new biomarkers for diagnosing and treating neuroendocrine tumors

  This study is testing new ways to diagnose and treat neuroendocrine tumors by looking at blood samples to see if they can provide better information about the cancer.

  Recruiting University of Roma La Sapienza · Rome, Italy · NCT04464122

• Chemotherapy for advanced neuroendocrine carcinoma

  This study is testing a new chemotherapy combination to see if it works better than the standard treatment for patients with advanced neuroendocrine carcinoma.

  Recruiting at 6 sites Phase 2 Centre Hospitalier Universitaire Dijon · Caen and 5 other locations · NCT04325425

• Neoadjuvant chemotherapy for localized digestive neuroendocrine carcinomas

  This study is testing a new 12-month chemotherapy treatment for people with localized digestive neuroendocrine carcinomas to see if it helps them live longer without the cancer coming back after surgery.

  Recruiting at 9 sites Phase 2 GERCOR - Multidisciplinary Oncology Cooperative Group · Amiens and 13 other locations · NCT04268121

• Molecular screening for relapsed small cell lung cancer patients

  This study is testing a way to analyze the DNA from tissue and blood samples of patients with relapsed small cell lung cancer to see if it can help identify who might benefit from new treatments.

  Recruiting Samsung Medical Center · Incheon and 5 other locations · NCT02688894

Related topics

Quick answers

How many Neuroendocrine Carcinoma clinical trials are recruiting right now?

14, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 6 countries. The most sites are in China (5 trials), France (4 trials), United States (2 trials), Poland (1 trial), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 4, Phase 2: 3, Phase 1: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →